LAGUNA HILLS, Calif. , Feb. 8, 2024 /PRNewswire/ Prelude Corporation (PreludeDx ), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, now declared the appointment of Chris Emery to the freshly produced posture of VP of Strategic...
Read More
LAGUNA HILLS, Calif. , Feb. 8, 2024 /PRNewswire/ Prelude Corporation (PreludeDx ), a leader in molecular diagnostics and precision...
Read More